Identification of HIV-1 Group O Infection - Los Angeles County, California, 1996

Morbidity and Mortality Weekly Report

Volumn 45, Issue 26, 1996, Pages 561-565

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; AFRICA; ARTICLE; CASE REPORT; CLASSIFICATION; EPIDEMIOLOGY; ETHNOLOGY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; MICROBIOLOGY; POLYMERASE CHAIN REACTION; SERODIAGNOSIS; UNITED STATES;

ADULT; AFRICA; AIDS SERODIAGNOSIS; DNA, VIRAL; EPIDEMIOLOGY, MOLECULAR; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; POLYMERASE CHAIN REACTION; UNITED STATES;

EID: 0030570271     PISSN: 01492195     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. De Leys R, Vanderborght B, Vanden Haesevelde M, et al. Isolation and partial characterization of an unusual human immunodeficiency retrovirus from two persons of West-Central African origin. J Virol 1990;64:1207-16.
2. Peeters M, Gaye A, Mboup S, et al. Presence of HIV-1 group O infection in West Africa [Letter]. AIDS 1996;10:343-4.
3. Mulanga Kabeya C, Esu-Williams E, Eni E, Peeters M, Saman E, Delaporte E. Evidence for HIV-1 group O infection in Nigeria [Letter]. Lancet 1995;346:308.
4. Loussert-Ajaka I, Ly TD, Chaix ML, et al. HIV-1/HIV-2 seronegativity in HIV-1 subtype O infected patients. Lancet 1994;343:1393-4.
5. Schable C, Zekeng L, Pau CP, et al. Sensitivity of United States HIV antibody tests for detection of HIV-1 group O infections. Lancet 1994;344:1333-4.
6. Pau CP, Hu DJ, Spruill C, et al. Surveillance for human immunodeficiency virus type 1 group O infections in the United States. Transfusion 1996;36:398-400.
7. Hu DJ, Dondero TJ, Rayfield MA, et al. The emerging genetic diversity of HIV: the importance of global surveillance for diagnostics, research, and prevention. JAMA 1996;275:210-6.
8. Zekeng L, Gurtler L, Afane Ze E, et al. Prevalence of HIV-1 subtype O infection in Cameroon: preliminary results [Letter]. AIDS 1994;8:1626-8.
9. Food and Drug Administration. Revised recommendations for the prevention of human immunodeficiency virus (HIV) transmission by blood and blood products [Memorandum to all registered blood establishments]. Bethesda, Maryland: US Department of Health and Human Services, Public Health Service, Food and Drug Administration, Center for Biologics Evaluation and Research, 1992.
10. CDC. U.S. Public Health Service guidelines for testing and counseling blood and plasma donors for human immunodeficiency virus type 1 antigen. MMWR 1996;45(no. RR-2).